ReflexMD Review
Appears to have shut downReflexMD's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
ReflexMD is no longer taking new patients. This program appears to have shut down, so we're not linking to it. Here are the top-rated GLP-1 providers we recommend instead.
See our top-rated GLP-1 providers →ReflexMD was a telehealth weight loss seller that offered compounded semaglutide and tirzepatide at flat monthly rates. Its website stopped resolving in July 2026, and the service no longer appears to be operating.
Vetted alternatives to ReflexMD
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
ReflexMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (Last price listed before ReflexMD shut down in July 2026.)
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letters found
How ReflexMD scores
Six columns, each one computed from something ReflexMD has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
4.5/10$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
6.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
7.0/10The price covers the medication, clinician visits and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on ReflexMD
Last checked June 2026- Checked the listed price across 3 dose or plan tiers
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for ReflexMD
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with ReflexMD involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1ReflexMD shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2ReflexMD does not require a live video visit before a first prescription.
- 3Ask ReflexMD which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 4The monthly price includes the medication, clinician visits and shipping.
- Lowest ongoing monthly price: semaglutide $199, tirzepatide $297. That leaves out membership fees, first-month rates and insurance copays.
- Confirm that ReflexMD serves your state before you start.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting ReflexMD
- Phone
- +1 888-807-2462
- ReflexMD offers email support
GLP-1 medications ReflexMD offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Last price listed before ReflexMD shut down in July 2026.
Last price listed before ReflexMD shut down in July 2026.
Oral tablets. Last price listed before ReflexMD shut down in July 2026.
Check the price yourself before you pay
Every figure here was read off ReflexMD's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to ReflexMD
- Offers both oral and injectable options, so the format is your choice
Against it
- Tirzepatide costs $297 a month, 19% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
ReflexMD is no longer taking new patients. What follows describes the program as it last ran, for anyone comparing it with a seller that is still open.
What ReflexMD charges
The standing price at ReflexMD is $199/month.
- Compounded semaglutide: $199/month
- Compounded tirzepatide: $297/month
- Semaglutide: $199/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so ReflexMD's $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
What ReflexMD dispenses
ReflexMD prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
ReflexMD tells you its price before you start the medical questionnaire. We found no FDA warning letters issued to ReflexMD. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If ReflexMD will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Our read
ReflexMD is no longer taking new patients, so the choice is among the sellers that are still open. HumeCare+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
ReflexMD's strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Where ReflexMD is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
- If you want a human checking in, not just a prescription, consider ShedRx.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this ReflexMD review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of June 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.